https://www.zonebourse.com/cours/action/CONCERT-PHARMACEUTICALS-I-15789602/actualite/Concert-Pharmaceuticals-Inc-Maintient-la-designation-de-therapie-revolutionnaire-du-deuruxoliti-43005110/?utm_source=telegram&utm_medium=social&utm_campaign=share